Navigation Links
Technical Briefing: Amgen, PDL BioPharma, Questcor Pharma, and BioCryst Pharma
Date:7/11/2013

LONDON, July 11, 2013 /PRNewswire/ --

On Wednesday, July 10, 2013, shares in biotechnology companies ended mostly higher even as the broader market ended on a mixed note. The major movers in the industry included Amgen Inc. (NASDAQ: AMGN), PDL BioPharma Inc. (NASDAQ: PDLI), Questcor Pharmaceuticals Inc. (NASDAQ: QCOR), and BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX). All these companies are tracked by AAAResearchReports.com. Free technical research reports on AMGN, PDLI, QCOR, and BCRX can be accessed by signing up at:

http://www.aaaresearchreports.com/register/  

Shares in Amgen Inc. rose sharply on Wednesday, extending their gains for the week. The company's shares oscillated between $98.02 and $102.33 before finishing the day 3.79% higher at $102.26. A total of 4.18 million shares were traded which is above the daily average volume of 3.55 million. The company's shares have gained 4.53% so far this week, compared to a gain of 1.27% in the S&P 500. However, in the last three months, the stock has fallen by 5.72%. Download free report on AMGN upon registration at:

http://www.AAAResearchReports.com/AMGN071113.pdf

PDL BioPharma Inc.'s stock edged higher on Wednesday, extending its gains for the week. The company's shares oscillated between $8.06 and $8.15 before closing the session 1.24% higher at $8.15. A total of 1.71 million shares were traded which is below the daily average volume of 1.95 million. PDL BioPharma's shares have gained 3.16% so far this week, and 7.24% in the past three months, thus outperforming the S&P 500. PDLI technical report can be accessed for free by signing up at:

http://www.AAAResearchReports.com/PDLI071113.pdf

Shares in Questcor Pharmaceuticals Inc. edged lower on Wednesday, reversing some of their gains for the week. The company's shares ended the day 1.36% lower at $47.20 after oscillating between $47.04 and $48.57. A total of 1.87 million shares were traded which is below the daily average volume of 2.02 million. Despite Wednesday's pullback, the company's shares have gained 1.20% in the last three days and 63.95% in the last three months. A free report on QCOR can be accessed by registering at:

http://www.AAAResearchReports.com/QCOR071113.pdf

BioCryst Pharmaceuticals Inc.'s stock ended slightly higher on Wednesday, finishing at $1.63, up 0.62% from its previous closing price. The company's shares oscillated between $1.61 and $1.65. A total of 330,626 shares were traded which is less than its daily average volume of 818,150. The company's shares have fallen by 6.32% in the last three months. Register with AAA Research Reports and download research on BCRX for free at:

http://www.AAAResearchReports.com/BCRX071113.pdf

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by a CFA. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider has, through Chartered Financial Analysts, only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.


'/>"/>
SOURCE AAA Research Reports
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Todays Technical View: Elan Corp., Amarin, Seattle Genetics, and Cubist Pharma
2. Invitation to Register: Annual Defense Threat Reduction Agency Basic Research Technical Review
3. BC Technical Acquires MEDX
4. Call for Papers for Pittcon 2014 Technical Program
5. Technical Workshops at OrthoTec 2013 Focus on Risk Management Throughout Medical Device Lifecycle and Robust Material Selection Process Development
6. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
7. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Book Titles Until the End of March at Chemical Publishing Company
8. Technical Analysis on VIVUS and Achillion Pharma: Highlights on These Biotech Companies
9. Technical Analysis on GNC Holdings and Walgreen: Drug Store Stocks Set to Provide Good Returns
10. New England Biolabs New Website Adds Technical Information, Easy Ordering, and Better Search
11. 20% Off Your Entire Order of Scientific, Technical, Medical (STM) Titles Until the End of December at Chemical Publishing Company
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita ... miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the subject of ... now. , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016 Houston Methodist Willowbrook Hospital ... Sports Association to serve as their official health ... Methodist Willowbrook will provide sponsorship support, athletic training ... association coaches, volunteers, athletes and families. ... Sports Association and to bring Houston Methodist quality ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016  A new partnership ... more accurate underwriting decisions in a fraction of ... competitively priced and high-value life insurance policies to ... With Force Diagnostics, rapid testing (A1C, ... data readings (blood pressure, weight, pulse, BMI, and ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):